The expression of GLP‐1 receptor mRNA and protein allows the effect of GLP‐1 on glucose metabolism in the human hypothalamus and brainstem

In the present work, several experimental approaches were used to determine the presence of the glucagon‐like peptide‐1 receptor (GLP‐1R) and the biological actions of its ligand in the human brain. In situ hybridization histochemistry revealed specific labelling for GLP‐1 receptor mRNA in several brain areas. In addition, GLP‐1R, glucose transporter isoform (GLUT‐2) and glucokinase (GK) mRNAs were identified in the same cells, especially in areas of the hypothalamus involved in feeding behaviour. GLP‐1R gene expression in the human brain gave rise to a protein of 56 kDa as determined by affinity cross‐linking assays. Specific binding of 125I‐GLP‐1(7–36) amide to the GLP‐1R was detected in several brain areas and was inhibited by unlabelled GLP‐1(7–36) amide, exendin‐4 and exendin (9–39). A further aim of this work was to evaluate cerebral‐glucose metabolism in control subjects by positron emission tomography (PET), using 2‐[F‐18] deoxy‐d‐glucose (FDG). Statistical analysis of the PET studies revealed that the administration of GLP‐1(7–36) amide significantly reduced (p < 0.001) cerebral glucose metabolism in hypothalamus and brainstem. Because FDG‐6‐phosphate is not a substrate for subsequent metabolic reactions, the lower activity observed in these areas after peptide administration may be due to reduction of the glucose transport and/or glucose phosphorylation, which should modulate the glucose sensing process in the GLUT‐2‐ and GK‐containing cells.

[1]  E. Van Schaftingen,et al.  Short‐term control of glucokinase activity: role of a regulatory protein , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[2]  D. Smith,et al.  A role for glucagon-like peptide-1 in the central regulation of feeding , 1996, Nature.

[3]  I. Valverde,et al.  Presence and characterization of glucagon-like peptide-1(7-36) amide receptors in solubilized membranes of rat adipose tissue. , 1993, Endocrinology.

[4]  J. Talairach,et al.  Co-Planar Stereotaxic Atlas of the Human Brain: 3-Dimensional Proportional System: An Approach to Cerebral Imaging , 1988 .

[5]  L. Weinstein,et al.  Receptor-effector coupling by G proteins: implications for normal and abnormal signal transduction. , 1992, Endocrine reviews.

[6]  J. Conlon,et al.  Receptors for glucagon-like peptide-1(7-36) amide on rat insulinoma-derived cells. , 1988, The Journal of endocrinology.

[7]  John R. Christiansen,et al.  GLP-1 (glucagon-like peptide 1) and truncated GLP-1, fragments of human proglucagon, inhibit gastric acid secretion in humans , 1989, Digestive Diseases and Sciences.

[8]  F M Matschinsky,et al.  Glucokinase as Glucose Sensor and Metabolic Signal Generator in Pancreatic β-Cells and Hepatocytes , 1990, Diabetes.

[9]  J. Grippo,et al.  Nuclear Import of Hepatic Glucokinase Depends upon Glucokinase Regulatory Protein, whereas Export Is Due to a Nuclear Export Signal Sequence in Glucokinase* , 1999, The Journal of Biological Chemistry.

[10]  J. Mark Treherne,et al.  Glucose-induced excitation of hypothalamic neurones is mediated by ATP-sensitive K+ channels , 2004, Pflügers Archiv.

[11]  J. Holst,et al.  Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine. , 1991, The Journal of clinical investigation.

[12]  T. Ono,et al.  Glucose and Osmosensitive Neurones of the Rat Hypothalamus , 1969, Nature.

[13]  E. Blázquez,et al.  Neural contribution to the effect of glucagon-like peptide-1-(7-36) amide on arterial blood pressure in rats. , 1999, American journal of physiology. Endocrinology and metabolism.

[14]  Karl J. Friston,et al.  Statistical parametric maps in functional imaging: A general linear approach , 1994 .

[15]  J. Holst,et al.  Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus. , 1992, The New England journal of medicine.

[16]  F. Mora,et al.  Selective release of glutamine and glutamic acid produced by perfusion of GLP-1(7–36) amide in the basal ganglia of the conscious rat , 1992, Brain Research Bulletin.

[17]  J. Egan,et al.  Glucagon-like peptide-1. , 2001, Recent progress in hormone research.

[18]  S. Kanse,et al.  Identification and characterization of glucagon‐like peptide‐1 7–36 amide‐binding sites in the rat brain and lung , 1988, FEBS letters.

[19]  J. Balibrea,et al.  Glucagon-like peptide-1(7-36) amide stimulates surfactant secretion in human type II pneumocytes. , 2001, American journal of respiratory and critical care medicine.

[20]  S. Bloom,et al.  GLUCAGON-LIKE PEPTIDE-1 7-36: A PHYSIOLOGICAL INCRETIN IN MAN , 1987, The Lancet.

[21]  E. Blázquez,et al.  Expression of glucose transporter isoform GLUT‐2 and glucokinase genes in human brain , 2004, Journal of neurochemistry.

[22]  E. Blázquez,et al.  Changes in arterial blood pressure and heart rate induced by glucagon-like peptide-1-(7-36) amide in rats. , 1994, The American journal of physiology.

[23]  J. Holst,et al.  Glucagon-Like Peptide I Receptors in the Subfornical Organ and the Area Postrema Are Accessible to Circulating Glucagon-Like Peptide I , 1996, Diabetes.

[24]  S. Mojsov,et al.  Tissue‐specific expression of the human receptor for glucagon‐like peptide‐I: brain, heart and pancreatic forms have the same deduced amino acid sequences , 1995, FEBS letters.

[25]  INTERNATIONAL SOCIETY FOR NEUROCHEMISTRY , 1976 .

[26]  E. Blázquez,et al.  Characterization of high‐affinity receptors for truncated glucagon‐like peptide‐1 in rat gastric glands , 1990, FEBS letters.

[27]  N. Hoosein,et al.  Identification of glucagon receptors in rat brain. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[28]  E. Blázquez,et al.  Colocalization of Glucagon‐Like Peptide‐1 (GLP‐1) Receptors, Glucose Transporter GLUT‐2, and Glucokinase mRNAs in Rat Hypothalamic Cells: Evidence for a Role of GLP‐1 Receptor Agonists as an Inhibitory Signal for Food and Water Intake , 1996, Journal of neurochemistry.

[29]  B. Thorens,et al.  Expression of the Glucagon‐Like Peptide‐1 Receptor Gene in Rat Brain , 1996, Journal of neurochemistry.

[30]  M. Magnuson,et al.  Analysis of upstream glucokinase promoter activity in transgenic mice and identification of glucokinase in rare neuroendocrine cells in the brain and gut. , 1994, The Journal of biological chemistry.

[31]  K. Hamacher,et al.  Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[32]  E. Blázquez,et al.  Glucagon-like peptide-1-(7-36)amide increases pulmonary surfactant secretion through a cyclic adenosine 3',5'-monophosphate-dependent protein kinase mechanism in rat type II pneumocytes. , 1998, Endocrinology.

[33]  L. Orci,et al.  Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing. , 1986, The Journal of biological chemistry.

[34]  F. Matschinsky.  Perspectives in Diabetes Glucokinase as Glucose Sensor and Metabolic Signal Generator in Pancreatic P-Cells and Hepatocytes , 2006 .

[35]  M. Caron,et al.  Adenylate cyclase-coupled beta-adrenergic receptors: structure and mechanisms of activation and desensitization. , 1983, Annual review of biochemistry.

[36]  E. Blázquez,et al.  Evidence that glucokinase regulatory protein is expressed 
and interacts with glucokinase in rat brain , 2002, Journal of neurochemistry.

[37]  J. Argente,et al.  Differential effects of the neonatal and adult sex steroid environments on the organization and activation of hypothalamic growth hormone-releasing hormone and somatostatin neurons. , 1993, Endocrinology.

[38]  G I Bell,et al.  Sequence, tissue distribution, and chromosomal localization of mRNA encoding a human glucose transporter-like protein. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[39]  T. Dinh,et al.  Localization of hindbrain glucoreceptive sites controlling food intake and blood glucose , 2000, Brain Research.

[40]  M E Phelps,et al.  Positron emission tomography provides molecular imaging of biological processes. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[41]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[42]  F. Mora,et al.  Structural Characterization by Affinity Cross‐Linking of Glucagon‐Like Peptide‐1(7–36)Amide Receptor in Rat Brain , 1995, Journal of neurochemistry.